location: Current position: Home >> Scientific Research >> Paper Publications

Evaluation of poly(D,L-lactide-co-glycolide) microspheres for the lung-targeting of yuanhuacine, a novel DNA topoisomerase I inhibitor

Hits:

Indexed by:期刊论文

Date of Publication:2009-05-01

Journal:JOURNAL OF DRUG TARGETING

Included Journals:PubMed、SCIE

Volume:17

Issue:4

Page Number:286-293

ISSN No.:1061-186X

Key Words:PLGA microspheres; lung targeting; yuanhuacine; fluorescent spiropyran labeled; anticancer

Abstract:The present study was intended to develop poly(D,L-lactide-co-glycolide) (PLGA; 50:50, 0.15 dL/g) microspheres (MS) loaded with yuanhuacine (YHC) for passive targeting in lung as well as providing a simple evaluation method for the targeting efficiency of MS. A kind of photochromic spiropyran dye was applied to label MS to clearly demonstrate the in vivo distribution characteristics through intravenous injection into mice and rabbits. Sections of 10-mu m thickness from different organs were cut using a microtome, and fluorescent microscopy was used to determine the biodistribution of the MS. The average particle size of MS was 9.0 mu m, and the glass transition temperature was 37-40 degrees C. In vitro, the cumulative release achieved 50.8% in 24 h. Histological sections from different organs indicated that the amount of MS in lung achieved maximum in 6 h, as about 8 times as in liver and 70 times higher than the average concentration of other organs. In vivo, MS were gradually swelled and drug concentration remained just 10% in 12 h, which would not result in long time embolization in the lung. This evaluation method supplies a simple and visualized channel in focus for the targeting efficiency of PLGA MS.

Pre One:新型阳离子螺吡喃化合物的合成及光致变色性

Next One:具有分子内电子转移特征的氨基蒽醌类有机化合物的合成及光物理性质研究